No Data
No Data
Marker Therapeutics (NASDAQ:MRKR) Shareholders Are up 20% This Past Week, but Still in the Red Over the Last Five Years
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Marker Therapeutics' Promising Cancer Therapy Progress
Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M
Express News | Marker Therapeutics Inc: Believes That Existing Cash and Cash Equivalents Will Fund Its Operating Expenses Into Q4 of 2025
Express News | Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
No Data